Table 3.
Summary of findings from previous studies
| Author | Year | Study type | Indication | Sample size (knees) | Follow-up (months) | ROM | KSS knee score | KSS function score | Symptom recurrence rate | Revision rate | Infection rate | Non-infectious complications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lucas et al. [12] | 1999 | Case series | Patellar clunk | 30 | 12 | 105.6–106.1 | 64–93 | 65–89 | 3.3% | 0 | 0 | 0 |
| Koh et al. [7] | 2008 | Case series | Patellar clunk | 12 | 13.4 | NR | 63.8–90.9 | 65.4–90.4 | 0 | NR | NR | NR |
| Williams et al. [13] | 1996 | Case series | Arthrofibrosis | 10 | 20 | 69.9–103 | 70.9–86.4 | 71–88 | 22.2% | 22.2% | 0 | 0 |
| Mont et al. [8] | 2006 | Case series | Arthrofibrosis | 18 | 30 | 63–94 | 34–77 | NR | 5.6% | 0 | NR | NR |
| Ohdera et al. [6] | 2004 | Case series | Hemarthrosis | 6 | 24 | NR | NR | NR | 66.7% | NR | NR | NR |
| Kindsfater et al. [21] | 1995 | Case series | Hemarthrosis | 4 | NR | NR | NR | NR | 50% | NR | NR | NR |
| Klinger et al. [10] | 2005 | Case series | Mixed | 27 | 34 | NR | 71–85 | 69–83 | 33.3% | 22.2% | 1/27 | 0 |
| van Mourik et al. [11] | 1998 | Case series | Mixed | 27 | NR | NR | NR | NR | 41.7% | 37.5% | NR | 0 |
| Wasilewski et al. [5] | 1989 | Case series | Mixed | 12 | 25 | 33–67 | NR | NR | NR | 50% | NR | NR |
| Diduch et al. [14] | 1997 | Case series | Mixed | 40 | 19.9 | 73–99* | 87 | 85 | 27.5% | 7.5% | 0 | 0 |
| Bocell et al. [15] | 1991 | Case series | Mixed | 53 | 27 | NR | NR | NR | 7.5% | 5.7% | 0 | 0 |
| Lovro et al. [17] | 2020 | Cohort study | Mixed | 192 | 65.4 | NR | NR | NR | NR | 18.8% | 6.3% | NR |
| Sekiya et al. [16] | 2017 | Case series | Mixed | 30 | 36 | 116.7–117.4 | 75.1–86.9 | NR | 37% | 0 | 0 | 0 |
Abbreviation: NR not reported
*The data only applies to patients with arthrofibrosis